Main container

Studio dell’ accoppiamento metabolico basato sul citrato come possibile bersaglio per il tumore della prostata avanzato e metastatizzato alle ossa (Citrate-mediated metabolic coupling: a target for advanced PROstate cancer in bone)

Title
Studio dell’ accoppiamento metabolico basato sul citrato come possibile bersaglio per il tumore della prostata avanzato e metastatizzato alle ossa (Citrate-mediated metabolic coupling: a target for advanced PROstate cancer in bone)
Code
PROBONE
Type
Sperimentale
Start Year
2025
Status
In Corso

Principal Investigator

Prof. Baldini Nicola

(Già professore Unibo e direttore Scienze e tecnologie biomediche e nanobiotecnologie IOR)

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more